The Fragile X Syndrome and Infantile Autism: a Prevalence Study Brian Herb Annex Yale University
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Neural Signatures of Autism
Neural signatures of autism Martha D. Kaisera, Caitlin M. Hudaca, Sarah Shultza,b, Su Mei Leea,b, Celeste Cheunga, Allison M. Berkena, Ben Deena, Naomi B. Pitskela, Daniel R. Sugruea, Avery C. Voosa, Celine A. Saulniera, Pamela Ventolaa, Julie M. Wolfa, Ami Klina, Brent C. Vander Wyka, and Kevin A. Pelphreya,b,1 aYale Child Study Center, Yale School of Medicine, New Haven, CT 06520, and bDepartment of Psychology, Yale University, New Haven, CT 06520 Edited by Dale Purves, Duke University Medical Center, Durham, NC, and approved October 13, 2010 (received for review July 19, 2010) Functional magnetic resonance imaging of brain responses to bi- well illustrated by the discovery that point-light displays (i.e., vid- ological motion in children with autism spectrum disorder (ASD), eos created by placing lights on the major joints of a person and unaffected siblings (US) of children with ASD, and typically devel- filming them moving in the dark), although relatively impov- oping (TD) children has revealed three types of neural signatures: (i) erished stimuli, contain sufficient information to identify the kind state activity, related to the state of having ASD that characterizes of motion being produced (e.g., walking, dancing, reaching), as the nature of disruption in brain circuitry; (ii) trait activity, reflecting well as the identity of the agent (8). Visual sensitivity to biological shared areas of dysfunction in US and children with ASD, thereby motion is an evolutionarily well-conserved and ontogenetically providing a promising neuroendophenotype to facilitate efforts to early-emerging mechanism that is fundamental to adaptive social bridge genomic complexity and disorder heterogeneity; and (iii) engagement (9); for example, newly hatched chicks recognize bi- compensatory activity, unique to US, suggesting a neural system– ological motion in point-light displays (10), and 2-d-old human level mechanism by which US might compensate for an increased infants preferentially attend to biological motion in point-light genetic risk for developing ASD. -
Autism Practice Parameters
American Academy of Child and Adolescent Psychiatry AACAP is pleased to offer Practice Parameters as soon as they are approved by the AACAP Council, but prior to their publication in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP). This article may be revised during the JAACAP copyediting, author query, and proof reading processes. Any final changes in the document will be made at the time of print publication and will be reflected in the final electronic version of the Practice Parameter. AACAP and JAACAP, and its respective employees, are not responsible or liable for the use of any such inaccurate or misleading data, opinion, or information contained in this iteration of this Practice Parameter. PRACTICE PARAMETER FOR THE ASSESSMENT AND TREATMENT OF CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER ABSTRACT Autism spectrum disorder (ASD) is characterized by patterns of delay and deviance in the development of social, communicative, and cognitive skills which arise in the first years of life. Although frequently associated with intellectual disability, this condition is distinctive in terms of its course, impact, and treatment. ASD has a wide range of syndrome expression and its management presents particular challenges for clinicians. Individuals with an ASD can present for clinical care at any point in development. The multiple developmental and behavioral problems associated with this condition necessitate multidisciplinary care, coordination of services, and advocacy for individuals and their families. Early, sustained intervention and the use of multiple treatment modalities are indicated. Key Words: autism, practice parameters, guidelines, developmental disorders, pervasive developmental disorders. ATTRIBUTION This parameter was developed by Fred Volkmar, M.D., Matthew Siegel, M.D., Marc Woodbury-Smith, M.D., Bryan King, M.D., James McCracken, M.D., Matthew State, M.D., Ph.D. -
Autism Guideline Jan2018.Pdf
DATE: January 2018 TEXAS CHILDREN’S HOSPITAL EVIDENCE-BASED OUTCOMES CENTER Screening and Diagnosis of Autism Spectrum Disorder (ASD) Evidence-Based Guideline Definition: (1) Autism Spectrum Disorder (ASD) per the DSM-5 Early Signs (2,5,6) encompasses four previously separate disorders that are Social Skills Deficits actually a single condition with different levels of symptom Early years severity in two core domains. These four disorders are the - Do not appear to seek connectedness DSM-IV Autistic Disorder (autism), Asperger’s Disorder, - Contentbeingalone Childhood Disintegrative Disorder, and Pervasive - Ignore parents’ bids for attention Developmental Disorder Not Otherwise Specified (PDD-NOS). - Seldom make eye contact or bid for others’ attention ASD is characterized in early childhood by 1) deficits in social with gestures or vocalizations communication and social interaction and 2) restricted - Deficits in joint attention repetitive behaviors, interests, and activities (RRBs). - Fail to follow a point and/or share expression - Failto point to “comment” Etiology: (2) Although ASDs are heritable neurodevelopmental - Failtorespondtoname conditions with strong genetic underpinnings, their exact - Selective hearing etiology is unknown. The etiology is multifactorial with a variety - Less imitation of genetic and, to a lesser extent, environmental factors Later years playing a role. ASDs can be either idiopathic or associated with - Difficulty sharing the emotional state of others in other diagnoses; most are idiopathic. cooperative -
May 9-12 Rotterdam Netherlands
2018 ANNUAL MEETING MAY 9-12 ROTTERDAM NETHERLANDS PROGRAM BOOK www.autism-insar.org INSAR 2018 Sponsors We thank the following organizations for their generous support of the INSAR Annual Meeting. Platinum Sponsor Level Gold Sponsor Level Silver Sponsor Level Autism Science Foundation Hilibrand Foundation Nancy Lurie Marks Family Foundation TABLE OF CONTENTS Sponsorship .................................Inside Front Cover TABLE OF CONTENTS Special Interest Groups Schedule .......................... 6 Speaker Ready Room ............................................ 6 De Doelen Floor Plans ........................................ 7-9 Meeting Information Schedule-At-A-Glance .................................... 10-12 In-Conjunction Events .................................... 13-14 Keynote Speakers .............................................. 15 Awardees ..................................................... 16-19 INSAR MISSION Acknowledgments .......................................... 20-21 STATEMENT To promote the highest quality INSAR Summer Institute .................................... 22 research in order to improve the Abstract Author Index ...................................... 134 lives of people affected by autism. General Information .......................................... 208 Exhibitors ....................................................... 210 Strategic Initiatives Setting the Bar: Increase the quality, AM diversity and relevance of research promoted through annual meetings, journal, Keynote Address ............................................... -
Placental Trophoblast Inclusions in Autism Spectrum Disorder George M
Placental Trophoblast Inclusions in Autism Spectrum Disorder George M. Anderson, Andrea Jacobs-Stannard, Katarzyna Chawarska, Fred R. Volkmar, and Harvey J. Kliman Background: Microscopic examination of placental tissue may provide a route to assessing risk and understanding underlying biology of autism. Methods: Occurrence of a distinctive microscopic placental morphological abnormality, the trophoblast inclusion, was assessed using archived placental tissue. The rate of occurrence of trophoblast inclusion-positive slides observed for 13 individuals with autism spectrum disorder (ASD) was compared to the rate in an anonymous consecutive birth cohort. Results: The occurrence of inclusion positive slides was significantly greater in the ASD group compared to the control group (6/27 slides, 22.2% vs. 12/154, 7.8%; Fisher Exact Test, two-tailed p ϭ .033; relative risk 2.85). The proportion of positive cases was also greater in the ASD group (5/13 cases, 38.5% vs. 8/61, 13.1%; Fisher Exact, two-tailed p ϭ .044; relative risk 2.93). Behavioral severity scores did not differ across groups of inclusion positive (N ϭ 4) and negative (N ϭ 8) ASD individuals. Conclusions: Although probably not functionally detrimental or causative, the greater occurrence of placental trophoblast inclusions observed in ASD individuals may reflect altered early developmental processes. Further research is required to replicate the basic finding, to understand the basis for the trophoblastic abnormality, and to determine the utility of the measure in early detection of ASD. Key Words: Autism, early screening, marker, placenta, trophoblast, genes, and in early screening or risk assessment. Although most trophoblast inclusion measurable biological phenotypes are expected to be multi- determined, they may actually offer advantages in reflecting win and family studies have provided convincing evi- convergent processes related to neurobiological abnormality. -
Evidence-Based Practices for Children with Autism Spectrum Disorders
Evidence-Based Practices for Children with Autism Spectrum Disorders Brian Reichow, Ph.D., BCBA-D Associate Professor, University of Florida Assistant Professor, Adjunct, Yale Child Study Center [email protected] S L I D E 0 Conflicts of Interest / Disclosure • Conflict of Interest: – Receive royalties from publications. – But no conflicts of interest S L I D E 1 Overview • Background and overview of Evidence-Based Practice – Google and EBP • EBP&Ts in Autism • Conclusions and future directions • Additional readings, resources, and references S L I D E 2 Evidence-Based Practices S L I D E 3 Evidence-Based Practice • Early (and still relevant) definition of evidence-based medicine (Sacket et al., 1995) – Three areas • Best research evidence • Clinical expertise Patient • Patient values Concerns EBM Best research Clinical evidence Expertise S L I D E 4 Evidence-Based Practice • Evidence-based practice (EBP) – Sometimes termed evidence based medicine (EBM) – Uses best empirical data as a basis for systematic decision making – Data/results that support EBP can come from several sources • These range in levels of rigor and significance from: – Meta-analytic studies and reviews of double blind, placebo controlled trials to – Much less controlled studies, e.g., without blind or control, or of case series – Single case reports – Accepted knowledge • Origins of EBP – A. Cochrane (1972) Effectiveness and Efficiency: Random Reflections on Health Services subsequent development of Cochrane Collaboration – McMaster Group (Sackett and Guyatt – latter -
Fragile X Syndrome
AUCD Annual Conference Research Symposium The Rapidly Changing Landscape of Fragile X Elizabeth Berry-Kravis MD PhD Rush University Medical Center Disclosures: EBK has received funding from Neuropharm LTD, Seaside Therapeutics , Novartis and Roche Pharmaceuticals to consult on trial design and conduct clinical trials in FXS Features of Fragile X Syndrome • Physical: large prominent ears, long face, large head, prominent jaw and forehead, midfacial hypoplasia hyperflexible joints, large testis • Intellectual Disability or LD • Behavior problems: hyperactivity distractibility, anxiety, perseveration • Autism: 18-36% AD, 43-67% ASD • Seizures – 15% • Strabismus – 30% • Medical: otitis, sinus, MVP, reflux, sleep apnea, loose stools, allergies FXS Treatment in Clinic - Rush FXS Clinic since 1992 > 450 patients Supportive • Aggressive tx of otitis – • Early intervention tubes/audiology • Intensive speech therapy • Manage sleep apnea – • OT with sensory integration T&A • Inclusion in school as much • Treat sleep dysregulation as possible – melatonin/medications • Educational curriculum, • Yearly eye exams – environment, teaching style patching, surgery, glasses matched to FXS cognitive • Control seizures profile • Orthopedics if needed • Socialization program • Monitor for MVP/heart • Behavior plan • Genetic counseling • Behavior medications for • Discuss reproductive ADD/anxiety options Seizures in Fragile X Syndrome – Recent and Largest Study National Fragile X Survey 1394 FXS full mutation (1090 M, 304 F) 173 (12%) seizures: 154 (14%) -
The Fragile X Syndrome–Autism Comorbidity: What Do We Really Know?
REVIEW ARTICLE published: 16 October 2014 doi: 10.3389/fgene.2014.00355 The fragile X syndrome–autism comorbidity: what do we really know? Leonard Abbeduto 1,2*, Andrea McDuffie 1,2 and Angela John Thurman 1,2 1 MIND Institute, University of California, Davis, Sacramento, CA, USA 2 Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento, CA, USA Edited by: Autism spectrum disorder (ASD) is a common comorbid condition in people with fragile Anne C. Wheeler, Carolina Institute X syndrome (FXS). It has been assumed that ASD symptoms reflect the same underlying for Developmental Disabilities; University of North Carolina at psychological and neurobiological impairments in both FXS and non-syndromic ASD, which Chapel Hill, USA has led to the claim that targeted pharmaceutical treatments that are efficacious for core Reviewed by: symptoms of FXS are likely to be beneficial for non-syndromic ASD as well. In contrast, we Molly Losh, Northwestern present evidence from a variety of sources suggesting that there are important differences University, USA in ASD symptoms, behavioral and psychiatric correlates, and developmental trajectories Dejan Budimirovic, Kennedy Krieger Institute/The Johns Hopkins between individuals with comorbid FXS and ASD and those with non-syndromic ASD. We University, USA also present evidence suggesting that social impairments may not distinguish individuals *Correspondence: with FXS with and without ASD. Finally, we present data that demonstrate that the Leonard Abbeduto, MIND Institute, neurobiological substrates of the behavioral impairments, including those reflecting core University of California, Davis, 2825 ASD symptoms, are different in FXS and non-syndromic ASD. Together, these data suggest 50th Street, Sacramento, CA 95817, USA that there are clinically important differences between FXS and non-syndromic ASD e-mail: leonard.abbeduto@ucdmc. -
Clinical Report—Health Supervision for Children with Fragile X Syndrome
Guidance for the Clinician in Rendering Pediatric Care Clinical Report—Health Supervision for Children With Fragile X Syndrome Joseph H. Hersh, MD, Robert A. Saul, MD, and COMMITTEE abstract ON GENETICS Fragile X syndrome (an FMR1–related disorder) is the most commonly KEY WORDS fragile X syndrome, FMR1–related conditions, mental inherited form of mental retardation. Early physical recognition is dif- retardation, health guidelines ficult, so boys with developmental delay should be strongly considered ABBREVIATIONS for molecular testing. The characteristic adult phenotype usually does FMR1—fragile X mental retardation 1 gene not develop until the second decade of life. Girls can also be affected CGG—cytosine-guanine-guanine FMRP—fragile X mental retardation 1 protein with developmental delay. Because multiple family members can be mGluR—metabotropic glutamate receptor affected with mental retardation and other conditions (premature POI—primary ovarian insufficiency ovarian failure and tremor/ataxia), family history information is of FXTAS—fragile X–associated tremor/ataxia syndrome critical importance for the diagnosis and management of affected pa- This document is copyrighted and is property of the American tients and their families. This report summarizes issues for fragile X Academy of Pediatrics and its Board of Directors. All authors have filed conflict of interest statements with the American syndrome regarding clinical diagnosis, laboratory diagnosis, genetic Academy of Pediatrics. Any conflicts have been resolved through counseling, related health problems, behavior management, and age- a process approved by the Board of Directors. The American related health supervision guidelines. The diagnosis of fragile X syn- Academy of Pediatrics has neither solicited nor accepted any commercial involvement in the development of the content of drome not only involves the affected children but also potentially has this publication. -
Fragile X Syndrome
Fragile X syndrome What is fragile X syndrome? Fragile X syndrome is an X-linked disease of intellectual disability with variable severity.1 Expansions of CGG repeat sequences in the FMR1 gene account for 99% of mutations causing fragile X syndrome. Interpretation of CGG repeat expansion results is based on the following ranges: Negative: <45 repeats; intermediate: 45-54 repeats; premutation: 55-200 repeats; full mutation: >200 repeats. Greater than 99% of males and approximately 50% of females with the full mutation are intellectually disabled.2 What are the symptoms of fragile X syndrome and what treatment is available? Fragile X syndrome is associated with a range of symptoms. Early signs include delayed speech and language skills.1 Intellectual problems vary from mild learning disabilities to severe intellectual disability.3 Behavioral characteristics include autism and hyperactivity.1 Physical features, such as a long face and large or prominent ears, are usually more noticeable in adults than in children, and in males more than females.3 There is no cure for fragile X syndrome. Treatment is supportive and focuses on educational and behavioral support and management of symptoms.2 Individuals with a premutation do not have fragile X syndrome, but may have an increased risk for fragile X-related disorders. Females may have fragile X-associated primary ovarian insufficiency (FXPOI), which can cause infertility or early menopause. Most males with a premutation and some females are at risk for fragile X-associated tremor and ataxia syndrome -
The Criminal Justice System and First Responders
UTISM PECTRUM EWS TM A YOUR TRUSTEDS SOURCE OF SCIENCE-BASED AUTISM EDUCATION,N FALL 2015 INFORMATION, ADVOCACY, AND COMMUNITY RESOURCES VOL. 8 NO. 2 Autism Safety: The Criminal Justice System and First Responders Both Individuals with Autism and Law Enforcement Benefit from Training By Nora Baladerian, PhD children with disabilities, Sullivan and It is my experience of over 35 years that Executive Director Knutson (2000) published their findings when police/sheriff and protective ser- The Disability and Abuse Project that children with disabilities in general vices workers begin their jobs, they do not experience abuse at 3.4 times the rate of receive training to work with individuals their generic counterparts. In 1994, Sob- with intellectual and developmental dis- hildren and adults with autism, sey’s review of studies indicated that abilities. I was recently asked to speak on like others, may in their child- adults with developmental disabilities are the training provided to Adult Protective hood or adulthood experience abused at rates ranging from 4-10 times Services workers in Los Angeles County. encounters with law enforce- that of neurotypical individuals. In the I learned that over the past 25 years there Cment. This may occur when the child/adult absence of a national survey, the Disabil- have been three announcements of a new with autism discloses abuse or their abuse ity and Abuse Project (Baladerian, Cole- online training. I took this training and is witnessed or suspected and reported man & Stream, 2012) conducted one to found that it included the words “develop- for investigation. At this sensitive point learn about prevalence as well as sequel- mentally disabled” once, and none of the in their lives, it is important not only that ae of abuse. -
A Functional MRI Study of Facial Emotion-Processing
G C A T T A C G G C A T genes Article Autism in Fragile X Syndrome; A Functional MRI Study of Facial Emotion-Processing Andrew G. McKechanie 1,2,* , Sonya Campbell 1, Sarah E. A. Eley 1 and Andrew C. Stanfield 1,2 1 The Patrick Wild Centre, The University of Edinburgh, Edinburgh EH10 5HF, UK; [email protected] (S.C.); [email protected] (S.E.A.E.); andrew.stanfi[email protected] (A.C.S.) 2 NHS Lothian, Edinburgh EH1 3EG, UK * Correspondence: [email protected]; Tel.: +44-131-537-6000 Received: 1 November 2019; Accepted: 13 December 2019; Published: 17 December 2019 Abstract: Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and autism spectrum disorder, and among those with fragile X syndrome, approximately 1/3rd meet a threshold for an autism spectrum disorder (ASD) diagnosis. Previous functional imaging studies of fragile X syndrome have typically focused on those with fragile X syndrome compared to either neurotypical or autism spectrum disorder control groups. Further, the majority of previous studies have tended to focus on those who are more intellectually able than is typical for fragile X syndrome. In this study, we examine the impact of autistic traits in individuals with fragile X syndrome on a paradigm looking at facial emotion processing. The study included 17 individuals with fragile X syndrome, of whom 10 met criteria for autism as measured by the Autism Diagnostic Observation Schedule (ADOS). Prior to the scan, participants rehearsed on a mock scanner to help acclimatize to the scanner environment and thus allow more severely affected individuals to participate.